Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Television presenter James Corden claimed the controversial drug - traditionally used to treat type II diabetes - 'didn't ...
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...
Television presenter James Corden has this week admitted to having used Ozempic as a means of losing weight, but insisted ...
Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to overdose.
The chief executive of the company behind Ozempic and Wegovy blamed insurers and middlemen for the high costs of weight-loss ...
Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer against the backdrop of surging investor enthusiasm.
To fight off compounding pharmacies, Eli Lilly wants access to medical records of patients who used copycat products.
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.